16 mars 2022
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.53738/REVMED.2022.18.773.471
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/35306767
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_F309F492FF173
info:eu-repo/semantics/openAccess , CC BY-NC-ND 4.0 , https://creativecommons.org/licenses/by-nc-nd/4.0/
R. Alexe et al., « Prise en charge des comorbidités chez les patients souffrant d’un rhumatisme inflammatoire [Management of comorbidities in patients suffering from inflammatory rheumatic diseases] », Serveur académique Lausannois, ID : 10.53738/REVMED.2022.18.773.471
In comparison to the general population, chronic inflammatory rheumatic diseases are more often associated with various comorbidities. Due to the important impact of these pathologies on the quality of life, on the choice of treatment and on the response to the latest, they need to be searched for actively. In this article, we present some of these comorbidities, as well as propositions for their management. We discuss the cardiovascular diseases, neoplasia, infections, interstitial lung disease and osteoporosis.